{"id":8575,"date":"2022-11-24T09:49:46","date_gmt":"2022-11-24T08:49:46","guid":{"rendered":"https:\/\/www.aieop.org\/web\/?p=8575"},"modified":"2022-12-02T09:42:14","modified_gmt":"2022-12-02T08:42:14","slug":"meet-aieops-working-groups-rare-tumors","status":"publish","type":"post","link":"https:\/\/www.aieop.org\/web\/meet-aieops-working-groups-rare-tumors\/","title":{"rendered":"Meet AIEOP\u2019s Working Groups: Rare Tumors"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 blog-article nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-right:120px;--awb-padding-left:120px;--awb-margin-top:60px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;--awb-margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-title title fusion-title-1 fusion-title-text fusion-title-size-two\"><h2 class=\"fusion-title-heading title-heading-left\" style=\"margin:0;\"><h2 class=\"title-heading-left\">MEET AIEOP\u2019S WORKING GROUPS!<\/h2><\/h2><span class=\"awb-title-spacer\"><\/span><div class=\"title-sep-container\"><div class=\"title-sep sep-double sep-solid\" style=\"border-color:#e0dede;\"><\/div><\/div><\/div><div class=\"fusion-text fusion-text-1\"><div><span style=\"font-family: georgia, serif;\">Each week we will be featuring two of AIEOP&#8217;s 29 Working Groups and their coordinators as an opportunity for the international medical community to get to know them and their important work!<\/span><b><\/b><\/div>\n<div style=\"text-align: center;\"><b><span style=\"font-family: georgia, serif;\"><br \/>\nMeet the Rare Tumors Working Group\u00a0<\/span><\/b><\/div>\n<div style=\"text-align: center;\"><b><span style=\"font-family: georgia, serif;\">&amp;\u00a0<\/span><\/b><\/div>\n<div style=\"text-align: center;\"><b><span style=\"font-family: georgia, serif;\">Coordinator Maria Debora De Pasquale<\/span><\/b><\/div>\n<div><\/div>\n<div><\/div>\n<div><\/div>\n<div><\/div>\n<div><\/div>\n<div><img decoding=\"async\" class=\"wp-image-8583 aligncenter\" src=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2022\/11\/FOTO-GdL-Tumori-Rari-1.jpg\" alt=\"\" width=\"449\" height=\"253\" \/><\/div>\n<div><span style=\"font-family: georgia, serif;\">\u00a0<\/span><\/div>\n<div><b><span style=\"font-family: georgia, serif;\"><br \/>\nTell us a little bit about your background as Coordinator of the Working Group?<\/span><\/b><b><\/b><\/div>\n<div><i><span style=\"font-family: georgia, serif;\">Since 2005, I have been working at the Bambino Ges\u00f9 Children\u2019s Hospital IRCCS in Rome, initially as a Resident. In 2007 I joined the Department of Oncohematology and Cellular Therapies. Since my residency years, I have been involved in the field of pediatric rare tumors, first as data manager for the Bambino Ges\u00f9 of the TREP project, and then as a referring physician for the treatment of rare cancers and germ cell tumors, writing articles in international journals in this field. I\u2019ve been the coordinator of AIEOP Rare Tumors WG since 2018.<\/span><\/i><\/div>\n<div><i><span style=\"font-family: georgia, serif;\">The rare tumors WG followed the experience of the 2010-born TREP Project with the intention of gathering and evaluating data and developing national treatment guidelines for children with very rare tumors\u00a0 (def. solid tumors with an incidence of less than 2 cases per million). The WG also works on liver cancers, retinoblastoma, and germ cell tumors.<\/span><\/i><\/div>\n<div><\/div>\n<div><\/div>\n<div><span style=\"font-family: georgia, serif;\"><b><br \/>\nWhat is the overall goal of the WG?<\/b><\/span><b><\/b><\/div>\n<div><i><span style=\"font-family: georgia, serif;\">The purpose of the WG is to promote cooperation between specialists from various countries in the field of rare childhood tumors in order to discuss and share data from previously treated patients to develop treatment guidelines for these tumors for which there are no pediatric-specific protocols.<\/span><\/i><\/div>\n<div><\/div>\n<div><\/div>\n<div><span style=\"font-family: georgia, serif;\"><b><br \/>\nWhat has been your WG\u2019s greatest accomplishment?<\/b><\/span><b><\/b><\/div>\n<div><i><span style=\"font-family: georgia, serif;\">The publication of guidelines for the diagnosis, treatment, and follow-up of rare tumors has been one of the most significant successes of our WG and the other European WG on rare childhood tumors. This has been made feasible through sharing of data between experts from different states. In this manner, patients are assured to receive the same treatment in all Italian and European centers, and thus have the same probability of recovery.<\/span><\/i><\/div>\n<div><\/div>\n<div><\/div>\n<div><span style=\"font-family: georgia, serif;\"><b><br \/>\nWhat message do you have to the international medical community or what is your hope for the future of your field of work globally?<\/b><\/span><b><\/b><\/div>\n<div><i><span style=\"font-family: georgia, serif;\">The message is to treat children with rare tumors in accordance with international guidelines and to maintain cooperation and data sharing between European and non-European centers in order to further improve treatment.<\/span><\/i><\/div>\n<div><\/div>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-8575","post","type-post","status-publish","format-standard","hentry","category-in-evidenza"],"_links":{"self":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/8575","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/comments?post=8575"}],"version-history":[{"count":7,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/8575\/revisions"}],"predecessor-version":[{"id":8624,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/8575\/revisions\/8624"}],"wp:attachment":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/media?parent=8575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/categories?post=8575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/tags?post=8575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}